Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | -534.81 Thousand AUD | -109.13% |
| 2023 | 5.85 Million AUD | 13.32% |
| 2022 | 5.16 Million AUD | -3.36% |
| 2021 | 5.34 Million AUD | -33.51% |
| 2020 | 8.04 Million AUD | 117.99% |
| 2019 | 3.68 Million AUD | 330.08% |
| 2018 | 857.64 Thousand AUD | 792.98% |
| 2017 | 96.04 Thousand AUD | 2970.38% |
| 2016 | -3346.00 AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | -1743.00 AUD | -100.03% |
| 2024 Q4 | -295.75 Thousand AUD | 0.0% |
| 2024 Q2 | 1.21 Million AUD | 0.0% |
| 2023 Q2 | 3.2 Million AUD | 0.0% |
| 2023 Q4 | 2.65 Million AUD | 0.0% |
| 2023 FY | 5.85 Million AUD | 13.32% |
| 2022 FY | 5.16 Million AUD | -3.36% |
| 2022 Q2 | 1.65 Million AUD | 0.0% |
| 2022 Q4 | 3.51 Million AUD | 0.0% |
| 2021 Q2 | 1.22 Million AUD | 0.0% |
| 2021 FY | 5.34 Million AUD | -33.51% |
| 2021 Q4 | 4.12 Million AUD | 0.0% |
| 2020 Q2 | 3.64 Million AUD | 0.0% |
| 2020 FY | 8.04 Million AUD | 117.99% |
| 2020 Q4 | 4.39 Million AUD | 0.0% |
| 2019 Q4 | 455.36 Thousand AUD | 0.0% |
| 2019 FY | 3.68 Million AUD | 330.08% |
| 2019 Q2 | 3.26 Million AUD | 0.0% |
| 2018 Q4 | 61.01 Thousand AUD | 0.0% |
| 2018 FY | 857.64 Thousand AUD | 792.98% |
| 2018 Q2 | 855.51 Thousand AUD | 0.0% |
| 2017 Q3 | - AUD | 0.0% |
| 2017 FY | 96.04 Thousand AUD | 2970.38% |
| 2017 Q2 | - AUD | 0.0% |
| 2017 Q4 | 126.29 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | -3346.00 AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 101.05% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 28.588% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | 5300.418% |
| Biome Australia Limited | 7.66 Million AUD | 106.973% |
| Patrys Limited | 1.39 Million AUD | 138.361% |
| Orthocell Limited | 3.68 Million AUD | 114.5% |
| Imugene Limited | -5.83 Million AUD | 90.842% |
| PYC Therapeutics Limited | 22.05 Million AUD | 102.424% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | 107.175% |
| Prescient Therapeutics Limited | 3.71 Million AUD | 114.406% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 52.385% |
| Cynata Therapeutics Limited | 2.31 Million AUD | 123.096% |
| CSL Limited | 15.28 Billion AUD | 100.003% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | -1958.628% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | -77.413% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 100.685% |
| Starpharma Holdings Limited | 7.65 Million AUD | 106.985% |
| Nanollose Limited | -348.95 Thousand AUD | -53.262% |
| Memphasys Limited | 1606.00 AUD | 33400.809% |
| Invex Therapeutics Ltd | 1.21 Million AUD | 144.117% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | -485.536% |
| Amplia Therapeutics Limited | 4.01 Million AUD | 113.334% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 91.837% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | 142.731% |
| Race Oncology Limited | 1.38 Million AUD | 138.478% |
| Nyrada Inc. | -5164.07 AUD | -10256.386% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 100.173% |
| Dimerix Limited | 583.47 Thousand AUD | 191.659% |
| PharmAust Limited | -1641.00 AUD | -32490.555% |
| Immutep Limited | 1.44 Million AUD | 137.039% |
| Clarity Pharmaceuticals Ltd | 11.5 Million AUD | 104.648% |
| Alterity Therapeutics Limited | 3.8 Million AUD | 114.056% |
| BTC Health Limited | 16.36 Thousand AUD | 3369.016% |
| Acrux Limited | -1.28 Million AUD | 58.348% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 100.261% |
| Biotron Limited | -40.49 Thousand AUD | -1220.586% |
| Tissue Repair Ltd | 150.51 Thousand AUD | 455.33% |
| AdAlta Limited | 1.5 Million AUD | 135.467% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 97.49% |
| Hexima Limited | - AUD | Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | 216.163% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | 1041.37% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | -45.817% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | -1121.169% |
| Actinogen Medical Limited | 9.93 Million AUD | 105.385% |
| Immuron Limited | 3.33 Million AUD | 116.028% |
| Argenica Therapeutics Limited | 2.59 Million AUD | 120.586% |